Overview
Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group.
Dr. Hahn is rated as an Experienced provider by MediFind in the treatment of Hemolytic Transfusion Reaction. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.
His clinical research consists of co-authoring 156 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemolytic Transfusion Reaction.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 North Caroline Street, Floor 4, Floor 4, Baltimore, MD 21287
10803 Falls Road, Pavilion III STE 1500, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Children's National Hospital
Jennifer Webb is a Hematologist and an Oncologist in Silver Spring, Maryland. Dr. Webb is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Transfusion Reaction. Her top areas of expertise are Sickle Cell Disease, Hemolytic Anemia, Anemia, Bone Marrow Transplant, and Splenectomy.
Children's National Hospital
Robert Nickel is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Nickel has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Transfusion Reaction. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant.
Limited To Official Government Duties On
Susan Leitman is an Oncologist in Bethesda, Maryland. Dr. Leitman is rated as an Experienced provider by MediFind in the treatment of Hemolytic Transfusion Reaction. Her top areas of expertise are Hemochromatosis, Graft Versus Host Disease (GvHD), Aplastic Anemia, Anemia, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Hahn isElite. Learn about Bladder Cancer.
- Muscle Invasive Bladder Cancer
- Upper Tract Urothelial Carcinoma (UTUC)
- Urothelial CancerDr. Hahn isElite. Learn about Urothelial Cancer.
- Distinguished
- Adult Soft Tissue SarcomaDr. Hahn isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Hahn isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Non-Muscle Invasive Bladder CancerDr. Hahn isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Renal Cell Carcinoma (RCC)Dr. Hahn isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- WT1-Related Wilms Tumor SyndromesDr. Hahn isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Clear Cell SarcomaDr. Hahn isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Hahn isAdvanced. Learn about Familial Wilms Tumor 2.
- Prostate CancerDr. Hahn isAdvanced. Learn about Prostate Cancer.
- Teratoma of the MediastinumDr. Hahn isAdvanced. Learn about Teratoma of the Mediastinum.
- Testicular CancerDr. Hahn isAdvanced. Learn about Testicular Cancer.
- Wilms TumorDr. Hahn isAdvanced. Learn about Wilms Tumor.
- Experienced
- ChoriocarcinomaDr. Hahn isExperienced. Learn about Choriocarcinoma.
- DehydrationDr. Hahn isExperienced. Learn about Dehydration.
- Familial Prostate CancerDr. Hahn isExperienced. Learn about Familial Prostate Cancer.
- Hemolytic Transfusion ReactionDr. Hahn isExperienced. Learn about Hemolytic Transfusion Reaction.
- HypophosphatemiaDr. Hahn isExperienced. Learn about Hypophosphatemia.
- Lymphoid HyperplasiaDr. Hahn isExperienced. Learn about Lymphoid Hyperplasia.